Patent Use Codes May Still Block Generics As FDA Looks For Alternatives
Executive Summary
FDA is assessing ways to alter how it handles patent use codes following charges they are being used to derail the approval of generics, but a straightforward solution has so far eluded the agency.
You may also be interested in...
FDA's Elizabeth Dickinson Is Named Acting Chief Counsel
Dickinson, who has been a staff attorney since 1994, takes the helm from Ralph Tyler on an interim basis.
Patent Use Codes: FDA Might Have Administrative Remedies, Solicitor General Says
In calling for the Supreme Court to take up a case involving the alteration of a patent use code to block generic competition, the Acting Solicitor General suggested steps FDA could take to address the problem.
Patent Use Codes: FDA Might Have Administrative Remedies, Solicitor General Says
In calling for the Supreme Court to take up a case involving the alteration of a patent use code to block generic competition, the Acting Solicitor General suggested steps FDA could take to address the problem.